Clinical Trial

Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis

Name: Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis — clinical trial record (NCT07491016)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The aim of this study is to observe the clinical efficacy and safety of telitacicept combined with baricitinib in the treatment of D2TRA patients

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-18.

Trial Details

NCT Number	NCT07491016
Lead Sponsor	Zhejiang Provincial People's Hospital
Conditions	Telitacicept, Treatment Compliance, Rheumatoid Arthritis
Enrollment	30 participants
Start Date	2026-03-01
Primary Completion	2027-03-30 (estimated)
Study Completion	2028-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-30